MiRNA-7 enhances erlotinib sensitivity of glioblastoma cells by blocking the IRS-1 and IRS-2 expression.

导出原文传递

翻译打印收藏纠错

第一作者： Vahab,Alamdari-Palangi

第一单位： Department of Molecular Medicine and Biotechnology, Faculty of Medicine, Arak University of Medical Sciences, Arak, Iran.

作者： Vahab,Alamdari-Palangi ^[1] ; Razieh,Amini ^[1] ; Hadi,Karami ^[2]

作者单位： Department of Molecular Medicine and Biotechnology, Faculty of Medicine, Arak University of Medical Sciences, Arak, Iran. ^[1] Department of Molecular Medicine and Biotechnology, Faculty of Medicine, Arak University of Medical Sciences, Arak, Iran.;Molecular and Medicine Research Center, Arak University of Medical Sciences, Arak, Iran. ^[2]

关键词 erlotinib glioblastoma insulin receptor substrate miRNA-7 sensitivity

主题词细胞凋亡(Apoptosis);细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);胶质母细胞瘤(Glioblastoma);人类(Humans);胰岛素受体底物蛋白质类(Insulin Receptor Substrate Proteins);微RNAs(MicroRNAs)

DOI 10.1111/jphp.13226

PMID 32026479

发布时间 2021-01-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交